9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding 9 Meters Biopharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 105 | +7 |
| Shares | 74.4M | 10.0K | 72.6M | −1.75M (−2.4%) |
| Value | $81.8M | $11.0K | $94.2M | +$12.4M (+15.2%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held 9 Meters Biopharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ghost Tree Capital, LLC | 2,750,000 | $3.58M | 1.18% |
| ODonnell Financial Services, LLC | 840,727 | $1.09M | 0.53% |
| Panagora Asset Management Inc | 315,867 | $411.0K | 0.00% |
| Goldman Sachs Group Inc | 138,958 | $181.0K | 0.00% |
| Stifel Financial Corp | 115,000 | $150.0K | 0.00% |
| AQR Capital Management LLC | 108,293 | $141.0K | 0.00% |
| MetLife Investment Management | 84,767 | $110.2K | 0.00% |
| Metropolitan Life Insurance Co | 64,133 | $83.4K | 0.00% |
| Mercer Global Advisors Inc | 60,000 | $78.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 52,330 | $68.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 39,300 | $51.0K | 0.00% |
| ExodusPoint Capital Management, LP | 32,600 | $42.0K | 0.00% |
| Boston Private Wealth LLC | 26,000 | $34.0K | 0.00% |
| Two Sigma Securities, LLC | 24,834 | $32.0K | 0.01% |
| Brown Advisory Inc | 14,430 | $19.0K | 0.00% |
| Gsa Capital Partners LLP | 14,108 | $18.0K | 0.00% |
| Mackenzie Financial Corp | 12,358 | $16.0K | 0.00% |
| Carnegie Capital Asset Management, LLC | 10,000 | $13.0K | 0.00% |
Sold out (11)
Institutions that held 9 Meters Biopharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Renaissance Technologies LLC | 1,305,027 | $1.44M |
| Two Sigma Investments, LP | 813,188 | $895.0K |
| Qube Research & Technologies Ltd | 274,665 | $302.0K |
| Cubist Systematic Strategies, LLC | 208,581 | $229.0K |
| Meridian Wealth Management, LLC | 100,000 | $110.0K |
| HRT Financial LP | 24,457 | $26.0K |
| Point72 Hong Kong Ltd | 12,813 | $14.0K |
| Cetera Advisor Networks LLC | 10,000 | $11.0K |
| FMR LLC | 1,685 | $2.00K |
| Advisory Services Network, LLC | 500 | $1.00K |
| Concord Wealth Partners | 1,000 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held 9 Meters Biopharma, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Rollins Financial | 10,000 | $11.0K |